DE3587549D1 - Ergänzungstestverfahren von proteine bindenden enzymen. - Google Patents

Ergänzungstestverfahren von proteine bindenden enzymen.

Info

Publication number
DE3587549D1
DE3587549D1 DE85905685T DE3587549T DE3587549D1 DE 3587549 D1 DE3587549 D1 DE 3587549D1 DE 85905685 T DE85905685 T DE 85905685T DE 3587549 T DE3587549 T DE 3587549T DE 3587549 D1 DE3587549 D1 DE 3587549D1
Authority
DE
Germany
Prior art keywords
test procedure
protein binding
supplementary test
binding enzymes
enzymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE85905685T
Other languages
English (en)
Other versions
DE3587549T2 (de
Inventor
Daniel Robert Henderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics Corp
Original Assignee
Microgenics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/721,267 external-priority patent/US4708929A/en
Priority claimed from US06/788,370 external-priority patent/US5120653A/en
Application filed by Microgenics Corp filed Critical Microgenics Corp
Application granted granted Critical
Publication of DE3587549D1 publication Critical patent/DE3587549D1/de
Publication of DE3587549T2 publication Critical patent/DE3587549T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE85905685T 1984-10-29 1985-10-28 Ergänzungstestverfahren von proteine bindenden enzymen. Expired - Fee Related DE3587549T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66608084A 1984-10-29 1984-10-29
US06/721,267 US4708929A (en) 1984-10-29 1985-04-08 Methods for protein binding enzyme complementation assays
US06/788,370 US5120653A (en) 1985-04-08 1985-10-22 Vector comprising DNA sequence coding for enzyme-donor polypeptide

Publications (2)

Publication Number Publication Date
DE3587549D1 true DE3587549D1 (de) 1993-09-30
DE3587549T2 DE3587549T2 (de) 1994-02-17

Family

ID=27418148

Family Applications (1)

Application Number Title Priority Date Filing Date
DE85905685T Expired - Fee Related DE3587549T2 (de) 1984-10-29 1985-10-28 Ergänzungstestverfahren von proteine bindenden enzymen.

Country Status (6)

Country Link
EP (1) EP0199801B1 (de)
JP (8) JPH0779717B2 (de)
AU (1) AU592324B2 (de)
CA (1) CA1340328C (de)
DE (1) DE3587549T2 (de)
WO (1) WO1986002666A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604091A (en) * 1984-03-01 1997-02-18 Microgenics Corporation Methods for protein binding enzyme complementation
US4956274A (en) * 1987-04-06 1990-09-11 Microgenics Corporation Reagent stabilization in enzyme-donor and acceptor assay
IL85596A (en) * 1987-05-18 1992-06-21 Technicon Instr Method for a specific binding enzyme immunoassay
GB8717791D0 (en) * 1987-07-28 1987-09-03 Baralle F E Immunoassay method
JP3282129B2 (ja) * 1987-09-21 2002-05-13 ロシュ ダイアグノスティクス コーポレイション 固相非分離酵素分析
US5212064A (en) * 1987-09-21 1993-05-18 Microgenics Corporation Solid phase non-separation enzyme complementation assay
US5244786A (en) * 1987-10-02 1993-09-14 Microgenics Corporation Method of measuring available free thyroxine bending sites
DE3889407T2 (de) * 1987-10-02 1994-11-03 Microgenics Corp Homogenes Verfahren zur Bestimmung der T-3- oder T-4-Aufnahme und Zusammensetzung dafür.
ATE104058T1 (de) * 1988-02-02 1994-04-15 Microgenics Corp Rezeptorpreincubations-enzymtest.
ES2093026T3 (es) * 1989-05-05 1996-12-16 Microgenics Corp Procedimiento de ensayo de complementacion enzimatico de enlace e proteinas.
CA1335707C (en) * 1989-08-15 1995-05-30 Pyare Khanna Drug screening assay
US5444161A (en) * 1989-08-16 1995-08-22 Microgenics Corporation Substrates for β-galactosidase
EP0419081A3 (en) * 1989-09-22 1992-07-22 Microgenics Corporation Method for protein binding enzyme complementation assays
DE4021063A1 (de) * 1990-07-03 1992-01-09 Boehringer Mannheim Gmbh Neue ss-galactosidase-substrate fuer den cedia
US5244785A (en) * 1991-02-01 1993-09-14 Microgenics Corporation Determination of high molecular weight analytes using a β-galactosidase complementation assay
CA2068190C (en) * 1991-05-15 1996-12-17 Microgenics Corporation Methods and compositions for enzyme complementation assays using the omega region of beta-galactosidase
GB9114525D0 (en) * 1991-07-05 1991-08-21 Delnatte Sabine Homogeneous nucleic acids probe based tests and substances
CA2075858C (en) * 1991-08-15 1998-05-19 Scott J. Eisenbeis Detection of complementary nucleotide sequences
US5976857A (en) * 1996-01-26 1999-11-02 Boehringer Mannheim Corporation Cross-linked polypeptide fragments of β-galactosidase
US5763196A (en) * 1996-01-26 1998-06-09 Boehringer Mannheim Corporation Assays using cross-linked polypeptide fragments of β-galactosidase
DE69709448T2 (de) * 1996-01-26 2002-09-19 Roche Diagnostics Corp Bismaleinsäureimid-vernetzer
EP1766095B1 (de) 2004-05-18 2013-10-23 The Board of Trustees of the Leland Stanford Junior University Nachweis der proteintranslokation durch beta-galactosidase-reporterfragment-komplementierung
WO2007069604A1 (ja) * 2005-12-14 2007-06-21 National University Corporation Hokkaido University 修飾蛋白質の製造方法
JP5739807B2 (ja) * 2008-08-18 2015-06-24 ディスカヴァーエックス コーポレイション 受容体チロシンキナーゼアッセイ
US9493503B2 (en) * 2011-02-02 2016-11-15 Neupharma, Inc. Certain chemical entities, compositions, and methods
CN103717751A (zh) * 2011-05-19 2014-04-09 塞昆纳姆股份有限公司 用于多重核酸鉴定的产品和方法
US8945853B2 (en) 2012-02-06 2015-02-03 Discoverx Corporation Detection of intracellular binding events by measuring protein abundance
CN107787371B (zh) 2015-04-24 2022-02-01 基纳生物技术有限公司 检测和定量次要变体的并行式方法
WO2016172571A1 (en) 2015-04-24 2016-10-27 Agena Bioscience, Inc. Multiplexed method for the identification and quantitation of minor alleles and polymorphisms
CN109797143B (zh) * 2016-09-22 2021-02-12 北京九强生物技术股份有限公司 一种包含大肠杆菌β半乳糖苷酶受体的试剂
CN114907472A (zh) * 2022-04-07 2022-08-16 武汉爱博泰克生物科技有限公司 一种精准复制抗体的方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
DE2712615A1 (de) * 1977-03-18 1978-09-21 Max Planck Gesellschaft Verfahren zur herstellung von filamentoesen phagen als vektor fuer synthetische rekombinate
US4378428A (en) * 1981-03-30 1983-03-29 Baker Instruments Corporation Method for carrying out non-isotopic immunoassays, labeled analytes and kits for use in such assays
MX197183A (es) * 1982-05-05 1994-02-28 Genentech Inc Activador de plasminogeno de tejido humano
US5077195A (en) * 1985-03-01 1991-12-31 Board Of Reagents, The University Of Texas System Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
JPH0779717A (ja) * 1993-09-17 1995-03-28 Tokihiko Yonamine スピルナ含有穀物

Also Published As

Publication number Publication date
JP2804918B2 (ja) 1998-09-30
EP0199801A1 (de) 1986-11-05
DE3587549T2 (de) 1994-02-17
JPS62500633A (ja) 1987-03-19
JP2538766B2 (ja) 1996-10-02
JPH0779717B2 (ja) 1995-08-30
JP2565669B2 (ja) 1996-12-18
JPH0882626A (ja) 1996-03-26
AU592324B2 (en) 1990-01-11
WO1986002666A1 (en) 1986-05-09
JPH0868793A (ja) 1996-03-12
JPH07179495A (ja) 1995-07-18
JP2807209B2 (ja) 1998-10-08
EP0199801A4 (de) 1988-12-15
JPH0862216A (ja) 1996-03-08
JPH08242870A (ja) 1996-09-24
JPH08256764A (ja) 1996-10-08
EP0199801B1 (de) 1993-08-25
JP2562286B2 (ja) 1996-12-11
AU5068385A (en) 1986-05-15
JP2602638B2 (ja) 1997-04-23
JPH0882624A (ja) 1996-03-26
CA1340328C (en) 1999-01-26

Similar Documents

Publication Publication Date Title
DE3587549T2 (de) Ergänzungstestverfahren von proteine bindenden enzymen.
DE3789664T2 (de) Neue thrombolytische proteine.
DE3586313D1 (de) Konjugate von pharmazeutisch nuetzlichen proteinen.
DE3584605D1 (de) Enzymelektroden.
IT1182721B (it) Procedimento di purificazione di proteine ossee
NO880329D0 (no) Enzymelektrode.
DK328585A (da) Modificerede succinimider, fremgangsmaade til deres fremstilling samt deres anvendelse
DE199644T1 (de) Enzymimmobilisierung.
DE3583947D1 (de) Modifizierte lipase.
DE3683032D1 (de) Summierung von adressenuebergangssignalen.
NO882226L (no) Fibrinolytiske proteiner.
NO873325D0 (no) Sekresjon av heterologe proteiner av gjaer.
DE3585657D1 (de) Gegenseitige trennung von proteinen.
ATE112172T1 (de) Targetformer von antitumor-methyltrithioagenzien.
DE3583355D1 (de) Gaerungsverfahren.
NO164392C (no) Fremgangsmaate for forbedring av hydrolysert protein.
DE3582267D1 (de) Elektrochemische oxydation von pyridinbasen.
DE3583953D1 (de) Einfuehrung von funktionellen monomeren.
NO162643C (no) Fremgangsmaate for fremstilling av mel med hoeyt proteininnhold.
DE3780199T2 (de) Modifiziertes enzym.
DE3583063D1 (de) Elektrochemische reduktion von cyanpyridin-basen.
DK582888D0 (da) Enzymassay
DK708988D0 (da) Enzym
ATE93546T1 (de) Ergaenzungstestverfahren von proteine bindenden enzymen.
DE3780280T2 (de) Enzymimmunotest.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ROCHE DIAGNOSTICS CORP., INDIANAPOLIS, IND., US

8339 Ceased/non-payment of the annual fee